(Q40738171)

23 September 2017

title

Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease (English)

1 reference

23 September 2017

1 reference

1 reference

Denis Guilloteau

7

0 references

Sylvie Chalon

object named as

Sylvie Chalon

2

0 references

author name string

Christelle Gouhier

1

1 reference

23 September 2017

Anne Aubert-Pouessel

3

1 reference

23 September 2017

Marie-Claire Venier-Julienne

4

1 reference

23 September 2017

Christophe Jollivet

5

1 reference

23 September 2017

Jean-Pierre Benoit

6

1 reference

23 September 2017

publication date

1 June 2002

1 reference

23 September 2017

1 reference

23 September 2017

volume

44

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

124-131

1 reference

Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.

23 September 2017

cites work

1 reference

Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

21 January 2018

1 reference

Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior

21 January 2018

1 reference

Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease.

21 January 2018

1 reference

Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

21 January 2018

1 reference

Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra.

21 January 2018

1 reference

Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide

21 January 2018

1 reference

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging.

21 January 2018

1 reference

Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms

21 January 2018

1 reference

Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats

21 January 2018

1 reference

Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?

21 January 2018

1 reference

Sham transplantation protects against 6-hydroxydopamine-induced dopaminergic toxicity in rats: behavioral and morphological evidence

21 January 2018

1 reference

Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease.

21 January 2018

1 reference

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

21 January 2018

1 reference

Measuring the progression of idiopathic Parkinson's disease with [123I] beta-CIT SPECT.

21 January 2018

1 reference

Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.

21 January 2018

1 reference

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

21 January 2018

1 reference

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

21 January 2018

1 reference

Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism

21 January 2018

1 reference

Surgical damage stimulates proliferation of dopamine uptake sites in normal mouse brain

21 January 2018

1 reference

Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/SYN.10063

1 reference

23 September 2017

1 reference